Abbey earnings smash Wall Street estimates. Here’s why the stock is down.

Abbey earnings smash Wall Street estimates.  Here's why the stock is down.

font size Wall Street is starting to wonder if the current environment is as good as it is for Derry. Justin Sullivan/Getty Images monastery It shattered Wall Street’s earnings estimates more Financial guidance for the fiscal year. However, the stock decreased. The current results have been impressive, but investors are worried about whether the current … Read more

J&J’s trade-in offer for Kenvue is about to expire. The division number will be the key.

J&J's trade-in offer for Kenvue is about to expire.  The division number will be the key.

font size Kenvue controls brands like Listerine, Band-Aid, and Tylenol. Justin Sullivan/Getty Images A key figure in Johnson Johnson’s $40 billion exchange bid Kinfu It will be the percentage, or percentage of J&J stock that has been exchanged for Kenvue stock. the Johnson & Johnson (ticker: JNJ) exchange offerunveiled on July 24, It is set … Read more

Tesla stock fell again for a new reason. Here’s where to go.

Tesla stock fell again for a new reason.  Here's where to go.

font size Tesla stock tends to rise faster than the Nasdaq when the index is up, but it falls faster when the benchmark is down. Philip Lopez/AFP via Getty Images EV stock leader Tesla They took a beating over the past two weeks, for reasons related to both the company and what’s happening in the … Read more

J&J’s Kenvo deal may be very popular. What happens if it is.

J&J's Kenvo deal may be very popular.  What happens if it is.

font size Johnson & Johnson took consumer health company Kenvue public in May. Mark Ralston / Getty Images Johnson and Johnson ‘s $40 billion stock exchange offer Kinfu It is likely to generate strong interest from the healthcare company’s shareholders, resulting in participants being able to swap only a portion of their J&J stock. Johnson … Read more